Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count

Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles

(2012) A La Marca et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Possibilities and Limits of Ovarian Reserve Testing in ART

(2012) Antonio La Marca et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols

(2012) Carlo Alviggi et al.   Reproductive Biology and Endocrinology

Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF

(2011) A. P. Yates et al.   HUMAN REPRODUCTION

ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria

(2011) A. P. Ferraretti et al.   HUMAN REPRODUCTION

Age-specific nomogram for the decline in antral follicle count throughout the reproductive period

(2010) Antonio La Marca et al.   FERTILITY AND STERILITY

AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis

(2010) S. L. Broer et al.   HUMAN REPRODUCTION UPDATE

Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study

(2010) F Olivennes et al.   REPRODUCTIVE BIOMEDICINE ONLINE

The antral follicle count: practical recommendations for better standardization

(2009) Frank J.M. Broekmans et al.   FERTILITY AND STERILITY

Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)

(2009) A. La Marca et al.   HUMAN REPRODUCTION UPDATE